ArticleEnhanced Radiation Dermatitis Associated With Concurrent Palliative Radiation and Vemurafenib TherapyAuthor:Wen Jiang Md, PhDPublish date: August 8, 2016Vemurafenib is a selective BRAF inhibitor that was approved by the US Food and Drug Administration (FDA) in August 2011 for the treatment of patien...Read More
